全文获取类型
收费全文 | 58831篇 |
免费 | 6151篇 |
国内免费 | 1692篇 |
专业分类
耳鼻咽喉 | 522篇 |
儿科学 | 1017篇 |
妇产科学 | 316篇 |
基础医学 | 6630篇 |
口腔科学 | 1151篇 |
临床医学 | 7895篇 |
内科学 | 14758篇 |
皮肤病学 | 857篇 |
神经病学 | 3590篇 |
特种医学 | 1026篇 |
外国民族医学 | 1篇 |
外科学 | 5179篇 |
综合类 | 8664篇 |
现状与发展 | 15篇 |
一般理论 | 4篇 |
预防医学 | 2998篇 |
眼科学 | 522篇 |
药学 | 5453篇 |
39篇 | |
中国医学 | 4475篇 |
肿瘤学 | 1562篇 |
出版年
2024年 | 83篇 |
2023年 | 1200篇 |
2022年 | 1209篇 |
2021年 | 2548篇 |
2020年 | 2575篇 |
2019年 | 2453篇 |
2018年 | 2260篇 |
2017年 | 2483篇 |
2016年 | 2629篇 |
2015年 | 2710篇 |
2014年 | 4045篇 |
2013年 | 4725篇 |
2012年 | 3464篇 |
2011年 | 3779篇 |
2010年 | 2960篇 |
2009年 | 2715篇 |
2008年 | 2597篇 |
2007年 | 2691篇 |
2006年 | 2394篇 |
2005年 | 2101篇 |
2004年 | 1719篇 |
2003年 | 1547篇 |
2002年 | 1319篇 |
2001年 | 1186篇 |
2000年 | 991篇 |
1999年 | 785篇 |
1998年 | 645篇 |
1997年 | 653篇 |
1996年 | 591篇 |
1995年 | 685篇 |
1994年 | 579篇 |
1993年 | 514篇 |
1992年 | 428篇 |
1991年 | 383篇 |
1990年 | 338篇 |
1989年 | 302篇 |
1988年 | 248篇 |
1987年 | 233篇 |
1986年 | 227篇 |
1985年 | 335篇 |
1984年 | 248篇 |
1983年 | 195篇 |
1982年 | 227篇 |
1981年 | 219篇 |
1980年 | 134篇 |
1979年 | 79篇 |
1978年 | 68篇 |
1977年 | 56篇 |
1976年 | 46篇 |
1973年 | 17篇 |
排序方式: 共有10000条查询结果,搜索用时 19 毫秒
91.
92.
93.
Xiuqin Li Hongze Wang Qingnian Chen Zhiqin Li Chao Liu Shengnan Yin Zhengchen You 《Fundamental & clinical pharmacology》2019,33(6):621-633
Felbamate is an anticonvulsant used in the treatment of epilepsy. In this study, we investigated the antidepressant‐like actions of felbamate in mice. The effects of felbamate were first assessed using the forced swimming test (FST) and tail suspension test (TST), and then investigated in the chronic unpredictable mild stress (CUMS) and chronic social defeat stress (CSDS) models of depression. The changes in the hippocampal brain‐derived neurotrophic factor (BDNF) signaling cascade after chronic stress and felbamate treatment were also examined. It was found that felbamate exhibited antidepressant‐like activities in the FST and TST without affecting the locomotor activity of mice. Felbamate was also effective in both the CUMS and CSDS models of depression. Moreover, felbamate administration fully restored the decreased hippocampal BDNF signaling pathway in both the CUMS‐stressed and CSDS‐stressed mice. Collectively, felbamate has antidepressant‐like actions in mice involving the hippocampal BDNF system. 相似文献
94.
95.
《Journal of vascular and interventional radiology : JVIR》2019,30(8):1265-1272
PurposeTo evaluate the safety and efficacy of balloon pulmonary angioplasty (BPA) for nonoperable chronic thromboembolic pulmonary hypertension (CTEPH) patients during the initial experience of a single center.MethodsA total of 18 CTEPH patients (5 with residual pulmonary hypertension after pulmonary endarterectomy) were treated with BPA during the period 2014–2018 and were retrospectively reviewed. Mean age was 61 ± 19 years; 55% were female; mean pulmonary artery pressure was 44 ± 12 mmHg; cardiac output was 4.3 ± 1.0 l/min; and pulmonary vascular resistance was 8.4 ± 3.6 WU. Patients were evaluated by New York Heart Association functional class, 6-minute walk distance, N-terminal pro b-type natriuretic peptide, echocardiography, right heart catheterization, and before and after completions of BPA.ResultsA total of 91 procedures were performed, with a median number of 4 BPA sessions per patient (range, 2–8). There were no deaths or major complications requiring extracorporeal support or (non)invasive ventilation. The most common complication was self-limiting hemoptysis (3%). According to Society of Interventional Radiology classification, 4 mild, 4 moderate, and 1 severe adverse events were noted. Invasive hemodynamics significantly improved, with a cardiac index increase of 15% (P = .0333), decrease of mean pulmonary artery pressure of 30% (P = .0013), and decrease of pulmonary vascular resistance of 45% (P = .0048). Stroke volume index (P = .0171) and pulmonary arterial compliance (P = .0004) were also significantly enhanced.ConclusionsBPA significantly improves cardiopulmonary hemodynamics with an acceptable safety profile. Further studies assessing the long-term efficacy of BPA are required. 相似文献
96.
Christopher Teng JiaDe Yu Jesse Taylor Adam I. Rubin James R. Treat 《Pediatric dermatology》2019,36(5):697-701
Erosive pustular dermatosis of the scalp (EPDS) is an uncommon chronic inflammatory response to scalp trauma that usually resolves with cicatricial alopecia. It most commonly affects elderly patients with a history of actinic damage. Herein, we describe a 16‐year‐old girl with acrofacial dysostosis type 1 presenting after surgery with crusting purulent scalp lesions, whose clinical presentation and histopathologic findings were consistent with EPDS. A review of the literature on EPDS in children is also detailed. 相似文献
97.
Periosteal new bone formation (PNBF) is a common finding in a large spectrum of diseases. In clinical practice, the morphology and location of periosteal lesions are frequently used to assist in the differential diagnosis of distinct bone conditions. Less commonly reported is the presence of PNBF on the ribs. This contrasts with the data retrieved from the study of skeletonized human remains that shows a high frequency of cases and a strong, albeit not specific, association between periosteal rib lesions and pulmonary conditions (e.g. tuberculosis). Despite that, an overall disagreement regarding the specificity and non‐specificity of periosteal reactions exists in the study of dry bone remains. The insufficient number of clinical models exploring the morphology and the pathophysiology of PNBF's and the lack of systematic studies of pathological samples with a known diagnosis are claimed as major reasons for the disagreements. This study aimed to describe and compare the macroscopic and the histomorphologic appearance of periosteal rib lesions and to discuss their usefulness as diagnostic indicators. To pursue this goal, an assemblage of 13 rib samples (males = 11, females = 2, mean age‐at‐death = 36.6 years old) was collected from the Luis Lopes Skeletal Collection (Museu Nacional de História Natural e da Ciência, Universidade de Lisboa, Portugal). The assemblage belongs to individuals who died from pulmonary‐TB (group 1), non‐TB pulmonary infections (group 2) and other conditions (group 3). Prior to sample preparation, the ribs were visually inspected and the PNBF described according to its thickness, the degree of cortical integration and the type of new bone formed (e.g. woven, lamellar or both). After sampling, each bone sample was prepared for histological analysis under plane and polarized light microscopy. Macroscopically, the results showed no differences in the new bone composition between cause‐of‐death groups. Only slight differences in the degree of cortical integration, which was most frequently classified as mild to high in the pulmonary‐TB group, were observed. Histologically, no distinguishing features were identified by pathological group. However, new bone microarchitectures were observed compatible with (1) acute, fast‐growing processes (e.g. spiculated reactions), (2) long‐standing processes with a rapid bone formation (e.g. appositional layering of bone) and/or (3) chronic, slow‐growing processes (e.g. layers of compact lamellae). To some extent, these distinct rates of disease progression resonate with the cause‐of‐death listed for some individuals. Despite the small sample size, the results of this investigation are in agreement with previous studies, according to which the macroscopic and histological appearance of periosteal formations are not specific for a particular pathological conditions. Nevertheless, the results support the conclusion that the morphology of periosteal lesions is a good biological indicator for inferring the rate of progression and duration of pathological processes. This study provides important reference data regarding the histomorphology of periosteal lesions that can be used for comparative purposes, as well as to narrow down the differential diagnosis in unidentified skeletal remains. 相似文献
98.
99.
Noemie Luong-Gardiol Imran Siddiqui Irene Pizzitola Beena Jeevan-Raj Mélanie Charmoy Yun Huang Anja Irmisch Sara Curtet Georgi S. Angelov Maxime Danilo Mélanie Juilland Beat Bornhauser Margot Thome Oliver Hantschel Yves Chalandon Gianni Cazzaniga Jean-Pierre Bourquin Joerg Huelsken Werner Held 《Cancer cell》2019,35(4):649-663.e10
100.
目的:探索芪参补气胶囊治疗稳定期慢性阻塞性肺疾病(COPD)肺气虚证的临床疗效与安全性。方法:选取2017年10月16日至2018年11月20日在新疆维吾尔族自治区克州人民医院呼吸内科门诊随诊的COPD稳定期肺气虚证患者480例作为研究对象,随机分为观察组和对照组,每组240例,进行为期52周的观察。2组患者均给予健康指导、家庭氧疗、沙美特罗替卡松粉吸入剂、竹沥胶囊等基础治疗;对照组在基础治疗上给予玉屏风胶囊口服,2粒/次,3次/d;观察组在基础治疗上给予芪参补气胶囊口服,3粒/次,3次/d。观察比较2组患者的相关指标。结果:观察组平均急性加重次数(1.62±0.93)次,对照组(1.83±0.97)次,观察组发作次数显著减少(t=2.262,P=0.012)。观察组相对于对照组的急性加重风险RR=0.869(0.763~0.988,P=0.032),降低了13.1%。伴有咳嗽、喘息、便秘或吸烟的患者,观察组急性加重风险更低(P<0.05)。观察组CAT评分、FEV1显著优于对照组(P<0.05)。观察组炎性反应指标(TNF-α、IL-6、IL-8)改善情况显著优于对照组。观察组不良事件发生率显著低于对照组。结论:芪参补气胶囊与玉屏风散均具有良好的提高免疫功能,改善COPD属肺气虚证者咳痰喘症状的作用。其中芪参补气胶囊减少急性加重风险的效果较玉屏风胶囊更好,且安全性良好,值得推广使用。 相似文献